NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
Details
- Buyer
- NHS England
- Supplier(s)
20 suppliers
- Abbvie Ltd
- Accord UK Ltd
- Alexion Pharmaceuticals
- Amgen Ltd
- Celltrion Healthcare United Kingdom Ltd
- CuraTeQ Biologics s.r.o.
- Dr Reddy's Laboratories (UK) Ltd
- FRESENIUS KABI LIMITED
- GLAXOSMITHKLINE UK LIMITED
- Janssen Cilag Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Liimted
- Roche Products Ltd
- Samsung Bioepis UK Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Thornton and Ross
- Zentiva Pharma UK Ltd
- Value
- £986,282,758
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 29 July 2025
- Source
- uk:contracts_finder
Tender description
NHS Framework Agreement for Branded Medicines - Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 CM/PHR/24/5680/01 - NHS Framework Agreement for Branded Medicines - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5680/02 - NHS Framework Agreement for Branded Medicines - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Timeline
- Completed: Award published29 July 2025Current notice
- Completed: Award date1 September 2025
- Next: Contract expiry date31 August 2027in 10 months
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 509£240.8m
- 445£6.2bn
- 408£112.0m
- 394£649.4m
- 324£1.2bn
- 321£24.6bn
- 290£1.6bn
- 259£3.1bn
- 163£126.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.